« Previous
Next »
Journal of Clinical Lipidology
Volume 2, Issue 6
, Pages
436-446
, December 2008
Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non–HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein
To access this article, please choose from the options below
PII: S1933-2874(08)00889-1
doi: 10.1016/j.jacl.2008.10.003
« Previous
Next »
Journal of Clinical Lipidology
Volume 2, Issue 6
, Pages
436-446
, December 2008
